- Home
- ERIE vs ILMN Comparison
ERIE vs ILMN Comparison
Compare ERIE & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERIE
- ILMN
- Stock Information
- Founded
- ERIE 1925
- ILMN 1998
- Country
- ERIE United States
- ILMN United States
- Employees
- ERIE N/A
- ILMN N/A
- Industry
- ERIE Specialty Insurers
- ILMN Medical Specialities
- Sector
- ERIE Finance
- ILMN Health Care
- Exchange
- ERIE Nasdaq
- ILMN Nasdaq
- Market Cap
- ERIE 19.2B
- ILMN 18.4B
- IPO Year
- ERIE 1995
- ILMN 2000
- Fundamental
- Price
- ERIE $286.43
- ILMN $120.21
- Analyst Decision
- ERIE
- ILMN Hold
- Analyst Count
- ERIE 0
- ILMN 15
- Target Price
- ERIE N/A
- ILMN $114.93
- AVG Volume (30 Days)
- ERIE 160.4K
- ILMN 1.9M
- Earning Date
- ERIE 10-30-2025
- ILMN 10-30-2025
- Dividend Yield
- ERIE 1.90%
- ILMN N/A
- EPS Growth
- ERIE 15.90
- ILMN N/A
- EPS
- ERIE 12.39
- ILMN 4.46
- Revenue
- ERIE $4,040,325,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- ERIE $10.96
- ILMN N/A
- Revenue Next Year
- ERIE $8.12
- ILMN $2.22
- P/E Ratio
- ERIE $23.19
- ILMN $27.05
- Revenue Growth
- ERIE 9.53
- ILMN N/A
- 52 Week Low
- ERIE $276.91
- ILMN $68.70
- 52 Week High
- ERIE $456.93
- ILMN $153.06
- Technical
- Relative Strength Index (RSI)
- ERIE 39.11
- ILMN 63.61
- Support Level
- ERIE $276.91
- ILMN $117.10
- Resistance Level
- ERIE $293.69
- ILMN $125.50
- Average True Range (ATR)
- ERIE 10.05
- ILMN 5.47
- MACD
- ERIE -0.11
- ILMN 0.43
- Stochastic Oscillator
- ERIE 23.34
- ILMN 82.87
About ERIE Erie Indemnity Company
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.